Erbitux 500 mg/100 ml, Infusionslösung

7680560720025 CH-56072 Infusionslösung
Erbitux 500 mg/100 ml, Infusionslösung
Erbitux 500 mg/100 ml, Infusionslösung
Erbitux 500 mg/100 ml, Infusionslösung
1 / 3
google

Article details

Package size
1 x 100
Selling units
1
Measure
ml
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
18/03/2025
Summary of Product Characteristics
Français
18/03/2025
Summary of Product Characteristics
Italien
18/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
288.0 MG Substance HBESI

Reimbursement information

Public price
CHF 1035.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2015

Authorization holder

Merck (Schweiz) AG

6300 Zug

Authorization information

Swissmedic authorization number
56072
Drug name
Erbitux, Infusionslösung
Galenic form
LSINF
ATC Code
L01FE01
Authorization status
Z
Dispensing category
A
First authorization
01/12/2003
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Kolorektalkarzinom, Plattenepithelkarzinom im Kopf-Hals-Bereich

Package details

Description (FR)
ERBITUX sol perf 500 mg/100ml flac 100 ml
Description (DE)
ERBITUX Inf Lös 500 mg/100ml Durchstf 100 ml
Market launch
15/09/2014
Narcotic (BTM)
No

Other package sizes (2)

ERBITUX sol perf vial 50 ml
1 x 50 ML
GTIN: 7680560720018
Not in V1
ERBITUX sol perf 100 mg/20ml flac 20 ml
1 x 20 ML
GTIN: 7680560720032
View